FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Granules Pharmaceuticals Inc.
Granules Pharmaceuticals Inc. announced the FDA approval of its ANDA for Hydrocodone Bitartrate and Acetaminophen, granting the company a strategic entry into the established analgesic market. This approval is expected to stimulate competition and bolster Granules' revenue growth potential within the widely prescribed pain management sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day